Balance Sheet LANXESS AG

Stocks

LXS

DE0005470405

Diversified Chemicals

Real-time Estimate Tradegate Other stock markets 06:13:20 2026-07-16 am EDT			5-day change	1st Jan Change
15.58 ^EUR	+0.87%		+4.70%	-11.52%

04:43am	German chemicals lobby sees output falling again in 2026	RE
Jul. 15	Chemical company BASF raises outlook but warns on Iran war risks	RE

00151bdf4d95a889ddee328ea4b.Ggkqo4VqqSe24zO7OOdecDfmDlORHwCP7Q44ur0h6Iw.aDBF2qgMmEDwonn8SrZtA3jRZQbTTXDfmWVdyul5kthNal7rsVzfZPWEWA

Published financial data: LANXESS AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	7.56B	8.09B	6.71B	6.37B	5.67B
Total Revenues	7.56B	8.09B	6.71B	6.37B	5.67B
Cost of Goods Sold, Total	5.71B	6.15B	5.45B	5.07B	4.54B
Gross Profit	1.84B	1.94B	1.27B	1.3B	1.13B
Selling General & Admin Expenses, Total	1.27B	1.4B	1.24B	1.18B	1.09B
R&D Expenses	115M	102M	99M	104M	96M
Other Operating Expenses	-23M	60M	12M	-6M	78M
Other Operating Expenses, Total	1.36B	1.56B	1.35B	1.28B	1.26B
Operating Income	486M	377M	-81M	23M	-134M
Interest Expense, Total	-67M	-75M	-70M	-47M	-44M
Interest And Investment Income	12M	7M	10M	6M	5M
Net Interest Expenses	-55M	-68M	-60M	-41M	-39M
Income (Loss) On Equity Invest.	-	3M	-172M	-133M	-162M
Currency Exchange Gains (Loss)	6M	5M	11M	15M	13M
Other Non Operating Income (Expenses)	14M	52M	-32M	19M	58M
EBT, Excl. Unusual Items	451M	369M	-334M	-117M	-264M
Restructuring Charges	-39M	-	-22M	-1M	-
Merger & Related Restructuring Charges	-16M	-11M	-52M	-	-
Impairment of Goodwill	-	-	-406M	-	-83M
Gain (Loss) On Sale Of Assets	1M	-3M	2M	1M	152M
Asset Writedown	-	-17M	-	-	-104M
Other Unusual Items	-94M	-81M	-135M	-80M	-172M
EBT, Incl. Unusual Items	303M	257M	-947M	-197M	-471M
Income Tax Expense	84M	72M	-105M	-21M	105M
Earnings From Continuing Operations	219M	185M	-842M	-176M	-576M
Earnings Of Discontinued Operations	48M	66M	1.29B	-	-
Net Income to Company	267M	251M	444M	-176M	-576M
Minority Interest	-	-1M	-1M	-1M	-1M
Net Income - (IS)	267M	250M	443M	-177M	-577M
Net Income to Common Incl Extra Items	267M	250M	443M	-177M	-577M
Net Income to Common Excl. Extra Items	219M	184M	-843M	-177M	-577M
Per Share Items
Net EPS - Basic	3.09	2.9	5.13	-2.05	-6.68
Basic EPS - Continuing Operations	2.54	2.13	-9.76	-2.05	-6.68
Basic Weighted Average Shares Outstanding	86.35M	86.35M	86.35M	86.35M	86.35M
Net EPS - Diluted	3.09	2.9	5.13	-2.05	-6.68
Diluted EPS - Continuing Operations	2.54	2.13	-9.76	-2.05	-6.68
Diluted Weighted Average Shares Outstanding	86.35M	86.35M	86.35M	86.35M	86.35M
Normalized Basic EPS	3.26	2.66	-2.43	-0.86	-1.92
Normalized Diluted EPS	3.26	2.66	-2.43	-0.86	-1.92
Dividend Per Share	1.05	1.05	0.1	0.1	0.1
Payout Ratio	32.21	36.4	20.54	-5.08	-1.56
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	934M	855M	420M	521M	332M
EBITA	598M	533M	87M	185M	14M
EBIT	486M	377M	-81M	23M	-134M
EBITDAR	943M	865M	431M	534M	344M
Effective Tax Rate - (Ratio)	27.72	28.02	11.09	10.66	-22.29
Total Current Taxes	25M	20M	18M	40M	32M
Total Deferred Taxes	59M	52M	-123M	-61M	73M
Normalized Net Income	282M	230M	-210M	-74.12M	-166M
Interest Capitalized	3M	2M	1M	-	-
Interest on Long-Term Debt	6M	4M	6M	6M	5M
Non-Cash Pension Expense	16M	19M	20M	20M	18M
Supplemental Operating Expense Items
Marketing Expenses	536M	593M	583M	583M	562M
Selling and Marketing Expenses	951M	1.06B	933M	890M	834M
General and Administrative Expenses	304M	319M	279M	258M	230M
Research And Development Expense From Footnotes	115M	102M	99M	104M	96M
Net Rental Expense, Total	9M	10M	11M	13M	12M
Imputed Operating Lease Interest Expense	1.59M	1.59M	1.72M	1.62M	1.52M
Imputed Operating Lease Depreciation	7.41M	8.41M	9.28M	11.38M	10.48M
Stock-Based Comp., Other (Total)	666K	-	-	-	-
Total Stock-Based Compensation	666K	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.13B	403M	496M	615M	497M
Short Term Investments	100M	-	-	-	-
Total Cash And Short Term Investments	1.23B	403M	496M	615M	497M
Accounts Receivable, Total	1.16B	1.01B	785M	855M	682M
Other Receivables	315M	243M	239M	188M	182M
Total Receivables	1.47B	1.25B	1.02B	1.04B	864M
Inventory	1.63B	1.86B	1.36B	1.35B	1.22B
Other Current Assets, Total	48M	1.33B	29M	443M	24M
Total Current Assets	4.39B	4.85B	2.91B	3.45B	2.61B
Gross Property Plant And Equipment	8.28B	7.46B	7.67B	7.81B	7.75B
Accumulated Depreciation	-5.7B	-5.14B	-5.39B	-5.67B	-5.92B
Net Property Plant And Equipment	2.58B	2.32B	2.28B	2.14B	1.83B
Long-term Investments	56M	91M	859M	706M	469M
Goodwill	1.32B	1.84B	1.38B	1.3B	1.08B
Other Intangibles, Total	1.07B	1.39B	1.24B	1.13B	935M
Accounts Receivable Long-Term	34M	70M	77M	34M	32M
Loans Receivable Long-Term	-	-	-	232M	261M
Deferred Tax Assets Long-Term	192M	54M	165M	167M	33M
Other Long-Term Assets, Total	872M	665M	746M	555M	501M
Total Assets	10.52B	11.28B	9.66B	9.71B	7.75B
Liabilities
Accounts Payable, Total	1.01B	709M	584M	648M	541M
Accrued Expenses, Total	343M	251M	175M	206M	145M
Current Portion of Long-Term Debt	628M	785M	22M	533M	577M
Current Portion of Leases	47M	45M	50M	51M	51M
Current Income Taxes Payable	25M	38M	42M	48M	43M
Unearned Revenue Current, Total	17M	10M	18M	20M	13M
Other Current Liabilities	311M	582M	283M	267M	190M
Total Current Liabilities	2.38B	2.42B	1.17B	1.77B	1.56B
Long-Term Debt	2.67B	3.27B	2.78B	2.29B	1.79B
Long-Term Leases	158M	147M	154M	139M	111M
Unearned Revenue Non Current	34M	27M	24M	22M	16M
Pension & Other Post Retirement Benefits	877M	367M	498M	429M	421M
Deferred Tax Liability Non Current	223M	284M	194M	168M	106M
Other Non Current Liabilities	414M	339M	330M	299M	240M
Total Liabilities	6.76B	6.85B	5.16B	5.12B	4.25B
Common Stock, Total	86M	86M	86M	86M	86M
Retained Earnings	267M	250M	443M	-177M	-577M
Comprehensive Income and Other	3.4B	4.08B	3.97B	4.68B	3.99B
Total Common Equity	3.76B	4.42B	4.5B	4.59B	3.5B
Minority Interest	6M	6M	6M	6M	5M
Total Equity	3.76B	4.43B	4.51B	4.59B	3.5B
Total Liabilities And Equity	10.52B	11.28B	9.66B	9.71B	7.75B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	86.35M	86.35M	86.35M	86.35M	86.35M
ECS Total Common Shares Outstanding	86.35M	86.35M	86.35M	86.35M	86.35M
Book Value / Share	43.5	51.2	52.13	53.11	40.48
Tangible Book Value	1.36B	1.18B	1.88B	2.16B	1.48B
Tangible Book Value Per Share	15.73	13.72	21.73	24.99	17.14
Total Debt	3.5B	4.25B	3.01B	3.01B	2.53B
Net Debt	2.27B	3.84B	2.51B	2.4B	2.04B
Debt Equivalent of Unfunded Proj. Benefit Obligation	717M	232M	361M	291M	293M
Debt Equivalent Oper. Leases	72M	80M	88M	104M	96M
Minority Interest, Total (Incl. Fin. Div)	6M	6M	6M	6M	5M
Equity Method Investments, Total	56M	91M	859M	706M	469M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	421M	418M	279M	266M	253M
Inventories - Work In Process, Total	1.21B	1.44B	1.08B	1.08B	968M
Inventories - Finished Goods, Total	-	-	-	-	-
Land - (BS)	1.38B	1.21B	1.22B	1.21B	1.14B
Machinery, Total	6.53B	5.85B	6.01B	6.16B	6.17B
Full Time Employees	12.98K	13.19K	10.98K	12.34K	11.71K
Part Time Employees	1.88K	1.98K	1.87K	-	-
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	10M	14M	12M	12M	8M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	267M	250M	443M	-177M	-577M
Depreciation & Amortization - CF	390M	380M	394M	398M	379M
Amortization of Goodwill and Intangible Assets - (CF)	112M	156M	168M	162M	148M
Depreciation & Amortization, Total	502M	536M	562M	560M	527M
(Gain) Loss From Sale Of Asset	-1M	3M	-2M	-1M	-80M
Asset Writedown & Restructuring Costs	11M	10M	434M	6M	279M
(Income) Loss On Equity Investments - (CF)	-	-3M	172M	133M	162M
Net Cash From Discontinued Operations	-32M	-28M	-14M	-	-
Other Operating Activities, Total	56M	22M	-1.35B	-51M	58M
Change In Accounts Receivable	-213M	62M	230M	-54M	85M
Change In Inventories	-441M	-403M	465M	-19M	47M
Change In Accounts Payable	241M	-130M	-118M	73M	-80M
Change in Other Net Operating Assets	17M	-160M	17M	38M	-132M
Cash from Operations	407M	159M	838M	508M	289M
Capital Expenditure	-479M	-407M	-326M	-320M	-319M
Sale of Property, Plant, and Equipment	3M	5M	3M	2M	5M
Cash Acquisitions	-1.01B	-1.12B	-	-	-
Divestitures	115M	8M	1.19B	-	443M
Investment in Marketable and Equity Securities, Total	928M	510M	-465M	43M	260M
Other Investing Activities, Total	7M	-43M	17M	12M	15M
Cash from Investing	-432M	-1.05B	423M	-263M	404M
Long-Term Debt Issued, Total	1.1B	1.38B	383M	20M	71M
Total Debt Issued	1.1B	1.38B	383M	20M	71M
Long-Term Debt Repaid, Total	-564M	-689M	-1.69B	-66M	-579M
Total Debt Repaid	-564M	-689M	-1.69B	-66M	-579M
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-86M	-91M	-91M	-9M	-9M
Common & Preferred Stock Dividends Paid	-86M	-91M	-91M	-9M	-9M
Other Financing Activities, Total	-63M	14M	-72M	-42M	-42M
Cash from Financing	389M	613M	-1.47B	-97M	-559M
Foreign Exchange Rate Adjustments	8M	-4M	-9M	5M	-14M
Net Change in Cash	372M	-283M	-214M	153M	120M
Supplemental Items
Cash Interest Paid	63M	65M	71M	42M	41M
Cash Income Tax Paid (Refund)	10M	-4M	53M	47M	27M
Levered Free Cash Flow	-158M	-1.09B	1.68B	-109M	565M
Unlevered Free Cash Flow	-117M	-1.04B	1.73B	-79.62M	592M
Change In Net Working Capital	444M	1.4B	-1.54B	334M	-468M
Net Debt Issued / Repaid	538M	690M	-1.3B	-46M	-508M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.13	2.16	-0.48	0.15	-0.96
Return on Total Capital	4.64	2.96	-0.63	0.19	-1.23
Return On Equity %	6.48	4.52	-18.85	-3.87	-14.24
Return on Common Equity	6.48	4.5	-18.9	-3.9	-14.28
Margin Analysis
Gross Profit Margin %	24.41	23.95	18.89	20.39	19.94
SG&A Margin	16.77	17.28	18.44	18.49	19.23
EBITDA Margin %	12.36	10.57	6.26	8.18	5.85
EBITA Margin %	7.91	6.59	1.3	2.91	0.25
EBIT Margin %	6.43	4.66	-1.21	0.36	-2.36
Income From Continuing Operations Margin %	2.9	2.29	-12.54	-2.76	-10.15
Net Income Margin %	3.53	3.09	6.6	-2.78	-10.17
Net Avail. For Common Margin %	2.9	2.27	-12.56	-2.78	-10.17
Normalized Net Income Margin	3.73	2.84	-3.12	-1.16	-2.93
Levered Free Cash Flow Margin	-2.1	-13.44	25.05	-1.71	9.96
Unlevered Free Cash Flow Margin	-1.54	-12.86	25.7	-1.25	10.44
Asset Turnover
Asset Turnover	0.78	0.74	0.64	0.66	0.65
Fixed Assets Turnover	3.19	3.3	2.92	2.88	2.86
Receivables Turnover (Average Receivables)	7.7	7.46	7.48	7.76	7.38
Inventory Turnover (Average Inventory)	4.23	3.52	3.38	3.74	3.54
Short Term Liquidity
Current Ratio	1.84	2	2.48	1.95	1.67
Quick Ratio	1.14	0.68	1.29	0.94	0.87
Operating Cash Flow to Current Liabilities	0.17	0.07	0.71	0.29	0.19
Days Sales Outstanding (Average Receivables)	47.41	48.94	48.82	47.14	49.45
Days Outstanding Inventory (Average Inventory)	86.36	103.67	107.94	97.78	103.22
Average Days Payable Outstanding	49.12	49.12	47.72	44.59	49.15
Cash Conversion Cycle (Average Days)	84.65	103.49	109.04	100.34	103.52
Long Term Solvency
Total Debt/Equity	93.14	95.93	66.78	65.59	72.37
Total Debt / Total Capital	48.22	48.96	40.04	39.61	41.99
LT Debt/Equity	75.2	77.19	65.19	52.87	54.43
Long-Term Debt / Total Capital	38.93	39.39	39.08	31.93	31.58
Total Liabilities / Total Assets	64.23	60.76	53.37	52.71	54.83
EBIT / Interest Expense	7.25	5.03	-1.16	0.49	-3.05
EBITDA / Interest Expense	14.75	12.17	6.87	12.4	8.93
(EBITDA - Capex) / Interest Expense	7.6	6.75	2.21	5.6	1.68
Total Debt / EBITDA	3.55	4.65	6.26	5.17	6.45
Net Debt / EBITDA	2.3	4.21	5.23	4.11	5.18
Total Debt / (EBITDA - Capex)	6.88	8.39	19.42	11.45	34.23
Net Debt / (EBITDA - Capex)	4.46	7.6	16.22	9.11	27.51
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	23.8	32.57	-16.99	-5.18	-10.89
Gross Profit, 1 Yr. Growth %	18.57	27.02	-34.54	2.37	-12.87
EBITDA, 1 Yr. Growth %	17.93	15.54	-50.7	24.05	-36.28
EBITA, 1 Yr. Growth %	27.51	17.14	-83.58	112.64	-92.43
EBIT, 1 Yr. Growth %	27.89	9.28	-121.66	-128.4	-682.61
Earnings From Cont. Operations, 1 Yr. Growth %	-75.91	59.48	-555.14	-79.1	227.27
Net Income, 1 Yr. Growth %	-69.83	-6.37	77.2	-139.95	225.99
Normalized Net Income, 1 Yr. Growth %	-62.09	17.76	-192.1	-64.66	123.95
Diluted EPS Before Extra, 1 Yr. Growth %	-75.38	58.62	-558.15	-79	225.99
Accounts Receivable, 1 Yr. Growth %	44.15	-12.86	-22.35	8.92	-20.23
Inventory, 1 Yr. Growth %	52.62	13.96	-26.92	-0.88	-9.42
Net Property, Plant and Equip., 1 Yr. Growth %	19.2	-10.3	-1.38	-6.3	-14.44
Total Assets, 1 Yr. Growth %	18.45	7.15	-14.37	0.48	-20.21
Tangible Book Value, 1 Yr. Growth %	-8.37	-12.42	58.98	15.03	-31.42
Common Equity, 1 Yr. Growth %	25.16	17.7	1.81	1.89	-23.79
Cash From Operations, 1 Yr. Growth %	-30.43	-60.93	427.04	-39.38	-43.11
Capital Expenditures, 1 Yr. Growth %	5.04	-4.01	-19.9	-1.84	-0.31
Levered Free Cash Flow, 1 Yr. Growth %	-147.54	341.3	-255.11	-106.48	-618.12
Unlevered Free Cash Flow, 1 Yr. Growth %	-130.87	404.12	-266.34	-104.61	-843.8
Dividend Per Share, 1 Yr. Growth %	5	0	-90.48	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.4	15.11	4.9	-11.28	-8.08
Gross Profit, 2 Yr. CAGR %	2.33	11.57	-8.81	-18.14	-5.56
EBITDA, 2 Yr. CAGR %	-0.58	3.9	-24.66	-21.8	-11.09
EBITA, 2 Yr. CAGR %	-1.55	6.6	-56.27	-40.92	-59.89
EBIT, 2 Yr. CAGR %	-4.24	-0.4	-51.55	-75.2	28.62
Earnings From Cont. Operations, 2 Yr. CAGR %	-4.67	-54.89	169.42	-2.46	-17.29
Net Income, 2 Yr. CAGR %	14.12	-46.85	28.81	-15.86	14.13
Normalized Net Income, 2 Yr. CAGR %	-6.91	-44.43	3.71	-42.95	-11.04
Diluted EPS Before Extra, 2 Yr. CAGR %	-6.27	-54.52	169.58	-1.92	-17.27
Accounts Receivable, 2 Yr. CAGR %	17.12	12.08	-17.7	-8.04	-6.79
Inventory, 2 Yr. CAGR %	16.9	31.88	-8.74	-14.89	-5.25
Net Property, Plant and Equip., 2 Yr. CAGR %	7.28	3.5	-5.95	-3.87	-10.46
Total Assets, 2 Yr. CAGR %	9.98	12.71	-4.19	-7.24	-10.46
Tangible Book Value, 2 Yr. CAGR %	16.83	-10.58	17.75	35.23	-11.18
Common Equity, 2 Yr. CAGR %	18.63	21.37	9.47	1.85	-11.88
Cash From Operations, 2 Yr. CAGR %	-20.44	-47.87	43.49	78.74	-41.27
Capital Expenditures, 2 Yr. CAGR %	-2.9	-5.53	-12.31	-11.33	-1.08
Levered Free Cash Flow, 2 Yr. CAGR %	-10.82	80.61	161.26	-68.29	-42.05
Unlevered Free Cash Flow, 2 Yr. CAGR %	-31.26	65.97	189.14	-72.29	-41.41
Dividend Per Share, 2 Yr. CAGR %	5.13	2.47	-69.14	-69.14	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.46	5.94	3.23	1.43	-11.15
Gross Profit, 3 Yr. CAGR %	1.91	3.21	-6.6	-5.23	-16.42
EBITDA, 3 Yr. CAGR %	-0.77	-3.28	-19.06	-11.04	-26.96
EBITA, 3 Yr. CAGR %	-2.14	-4.76	-42.97	-25.92	-70.22
EBIT, 3 Yr. CAGR %	-4.33	-10.73	-40.26	-59.45	-28.98
Earnings From Cont. Operations, 3 Yr. CAGR %	-8.08	-8.44	-2.52	14.91	46.02
Net Income, 3 Yr. CAGR %	-14.75	6.84	-20.6	-12.81	32.15
Normalized Net Income, 3 Yr. CAGR %	11.22	-10.96	-34.42	-27.56	-10.01
Diluted EPS Before Extra, 3 Yr. CAGR %	6.9	-9.62	-1.77	15.13	46.37
Accounts Receivable, 3 Yr. CAGR %	6.97	6.13	-0.79	-9.64	-12.3
Inventory, 3 Yr. CAGR %	6.63	15.91	8.32	-6.19	-13.11
Net Property, Plant and Equip., 3 Yr. CAGR %	6.56	1.13	1.85	-6.07	-7.53
Total Assets, 3 Yr. CAGR %	6.58	9.07	2.86	-2.66	-11.79
Tangible Book Value, 3 Yr. CAGR %	7.6	6	8.18	16.84	7.84
Common Equity, 3 Yr. CAGR %	10.55	18.32	14.47	6.88	-7.54
Cash From Operations, 3 Yr. CAGR %	-11.44	-37.23	12.73	7.67	22.04
Capital Expenditures, 3 Yr. CAGR %	-0.21	-7.12	-10.58	-8.95	-7.8
Levered Free Cash Flow, 3 Yr. CAGR %	-37.85	76.06	71.51	-23.8	-19.54
Unlevered Free Cash Flow, 3 Yr. CAGR %	-45.16	61.56	65.93	-27.2	-17.04
Dividend Per Share, 3 Yr. CAGR %	5.27	3.39	-53.58	-54.33	-54.33
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.37	4.37	-0.32	-1.32	-1.45
Gross Profit, 5 Yr. CAGR %	0.91	2.24	-6.17	-5.93	-6.18
EBITDA, 5 Yr. CAGR %	-0.59	-1.02	-15.17	-11.23	-15.96
EBITA, 5 Yr. CAGR %	2.72	-2.31	-32.87	-21.41	-50.46
EBIT, 5 Yr. CAGR %	-0.16	-6.83	-31.95	-46.61	-18.82
Earnings From Cont. Operations, 5 Yr. CAGR %	2.35	25.26	24.46	-6.09	-8.72
Net Income, 5 Yr. CAGR %	6.82	23.5	0.55	-2.89	-8.2
Normalized Net Income, 5 Yr. CAGR %	2.83	-2.72	0.47	-25.6	-25.91
Diluted EPS Before Extra, 5 Yr. CAGR %	3.87	53.35	36.29	-6.62	-8.29
Accounts Receivable, 5 Yr. CAGR %	1.27	-5.16	-3.68	0.24	-3.24
Inventory, 5 Yr. CAGR %	2.7	2.07	0.19	2.44	2.68
Net Property, Plant and Equip., 5 Yr. CAGR %	-3.91	-8.3	1.41	-0.9	-3.27
Total Assets, 5 Yr. CAGR %	1.27	1.62	2.16	2.23	-2.69
Tangible Book Value, 5 Yr. CAGR %	-8.3	16.51	11.47	16.75	-0.03
Common Equity, 5 Yr. CAGR %	8.04	14.09	10.12	11.43	3.09
Cash From Operations, 5 Yr. CAGR %	-9.99	-28.78	7.42	-4.6	-13.15
Capital Expenditures, 5 Yr. CAGR %	1.76	0.5	-7.52	-8.83	-6.9
Levered Free Cash Flow, 5 Yr. CAGR %	-38.93	-10.96	20.57	-11.36	11.12
Unlevered Free Cash Flow, 5 Yr. CAGR %	-42.25	-12.27	19.54	-20.24	9.41
Dividend Per Share, 5 Yr. CAGR %	8.45	5.59	-35.56	-36.25	-36.9